| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/05/2013 | US8389209 Test device for rapid diagnostics |
| 03/05/2013 | US8389207 Methods for identifying candidate fat-mobilizing agents |
| 03/05/2013 | US8388979 Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell |
| 03/05/2013 | US8388975 Cancer antigen peptides derived from WT1 |
| 03/05/2013 | US8388972 Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma |
| 03/05/2013 | US8388957 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 03/05/2013 | US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 03/05/2013 | US8388930 Diagnosis and assessment of skeletal related disease using calcium 41 |
| 03/05/2013 | US8388913 Reagent container system |
| 03/05/2013 | US8388911 Filtration container |
| 03/05/2013 | US8388908 Fluidic devices with diaphragm valves |
| 03/05/2013 | US8388906 Containers; diagnositc codes |
| 03/05/2013 | US8388905 Method and apparatus for coding diagnostic meters |
| 03/05/2013 | US8388827 Methods of using an electrochemical biosensor |
| 03/05/2013 | US8388820 Biosensor, biosensor chip and biosensor device |
| 03/05/2013 | US8388551 Method and apparatus for multi-use body fluid sampling device with sterility barrier release |
| 03/05/2013 | DE202012105015U1 Einrichtung mit einem inneren und einem äußeren Funktionselement Means having an inner and an outer functional element |
| 03/05/2013 | CA2667957C Methods and apparatuses for electrochemical determination of factor xa inhibitors in blood samples |
| 03/05/2013 | CA2585788C Use of cyfra 21-1 as a marker for colorectal cancer |
| 03/05/2013 | CA2492380C An exposure device |
| 03/01/2013 | CA2788122A1 Apparatus and method for reducing vibrations of scanning sensors in web manufacturing or processing systems |
| 02/28/2013 | WO2013029047A1 Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures |
| 02/28/2013 | WO2013028996A1 Self-assembled bead-based multiplexed assay for antigen-specific antibodies |
| 02/28/2013 | WO2013028957A1 Autonomous process instrument flushing |
| 02/28/2013 | WO2013028807A2 Renal cell carcinoma biomarkers and uses thereof |
| 02/28/2013 | WO2013028784A1 Controller for optical analyte sensor |
| 02/28/2013 | WO2013028774A1 Analysis of dried blood spot samples in a microfluidic system with dilution of extracted samples |
| 02/28/2013 | WO2013028759A1 Assessing coagulation |
| 02/28/2013 | WO2013028706A1 Rapid detection of metabolic activity |
| 02/28/2013 | WO2013028611A1 Isolation of factors that associate directly or indirectly with non-coding rnas |
| 02/28/2013 | WO2013028596A1 Analyte sensors and systems including retention tab and methods of manufacturing |
| 02/28/2013 | WO2013028548A2 Compositions and devices for the detection of biomarkers in the gastrointestinal tract and methods for making and using them |
| 02/28/2013 | WO2013028137A1 A protein involved in detection of cancer metastasis and a treatment thereof |
| 02/28/2013 | WO2013028069A1 Thermostable inhibitors of activation of the blood clotting system through contact with foreign surfaces. |
| 02/28/2013 | WO2013027986A2 Method of screening for chaperonin modulator |
| 02/28/2013 | WO2013027896A1 Microchip |
| 02/28/2013 | WO2013027823A1 Method for determining glucagon-like peptide-1, and kit for use in said method |
| 02/28/2013 | WO2013027796A1 IgG-BINDING PEPTIDE AND METHOD FOR DETECTING AND PURIFYING IgG USING SAME |
| 02/28/2013 | WO2013027777A1 Biochip substrate and method for producing same |
| 02/28/2013 | WO2013027611A1 Leukocyte measurement device and reagent kit |
| 02/28/2013 | WO2013027399A1 Information processing system, information processing method, information processing device, and method and program for controlling same |
| 02/28/2013 | WO2013027338A1 Image sensor, method of manufacturing same, and inspection device |
| 02/28/2013 | WO2013027198A1 Light signaling system for plant behavior manipulation |
| 02/28/2013 | WO2013027149A1 Improved vaccine diagnostics |
| 02/28/2013 | WO2013027011A1 Categorisation of biological deposits using matrix assisted laser desorption ionisation mass spectrometry |
| 02/28/2013 | WO2013027008A1 Protein detection |
| 02/28/2013 | WO2013026919A1 Method for coating substrates with at least one monolayer of self-assembling proteins |
| 02/28/2013 | WO2013026871A1 High-precision determination of the mass proportion of a component in a multi-component fluid |
| 02/28/2013 | WO2013026808A1 Novel poc test system and method |
| 02/28/2013 | WO2013026807A1 Novel method for diagnosis of high-affinity binders and marker sequences |
| 02/28/2013 | WO2013026790A1 Luminescent lanthanide chelates having three chromophores and their use |
| 02/28/2013 | WO2013026677A1 Ir spectrometry cell with temperature control means |
| 02/28/2013 | WO2013026576A2 Cholesterol oxidase |
| 02/28/2013 | WO2013026222A1 Liquid-property detection method and system |
| 02/28/2013 | WO2013026123A1 Use of a protein nanopore for the detection, identification, quantification and real-time monitoring of microcystins in aqueous systems |
| 02/28/2013 | WO2013003112A9 Methods and compositions for treatment of cancer and autoimmune disease |
| 02/28/2013 | WO2013002552A3 Time-temperature indicator, method for manufacturing the time-temperature indicator, quality guarantee system using the time-temperature indicator, and quality guarantee method using the quality guarantee system |
| 02/28/2013 | WO2013000920A3 Methods for identifying candidate compounds for treating and/or limiting development of diabetes |
| 02/28/2013 | WO2012177945A3 Diagnostic methods for eosinophilic esophagitis |
| 02/28/2013 | WO2012174498A3 Biomarkers for epithelial cancer diagnosis and treatment |
| 02/28/2013 | WO2012174476A3 Antisense modulation of fibroblast growth factor receptor 4 expression |
| 02/28/2013 | WO2012170580A3 Optical method and apparatus for determining a characteristic such as volume and density of an excavated void in a construction material |
| 02/28/2013 | WO2012170206A3 Color-producing diagnostic systems, reagents and methods |
| 02/28/2013 | WO2012167145A3 Genome-scale analysis of aberrant dna methylation in colorectal cancer |
| 02/28/2013 | WO2012162701A3 Oil detection process, apparatus and taggant therefor |
| 02/28/2013 | WO2012158960A3 Melanocortin 1 receptor ligands and methods of use |
| 02/28/2013 | WO2012158238A3 Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender |
| 02/28/2013 | WO2012158195A3 Toxin and pathogen clearance |
| 02/28/2013 | WO2012156476A9 Methods for screening substances capable of modulating the replication of an influenza virus |
| 02/28/2013 | WO2012145414A9 Apparatus and method for separating and concentrating fluids containing multiple components |
| 02/28/2013 | WO2012142409A3 Diagnostic markers and therapeutic targets of kawasaki disease |
| 02/28/2013 | WO2012142003A3 Chemical ligation |
| 02/28/2013 | WO2012139021A3 TARGETING HK alpha FOR CONTROLLING BLOOD PRESSURE AND REGULATING ELECTROLYTE BALANCE |
| 02/28/2013 | WO2012137180A3 Biomarkers of immunotherapy efficacy |
| 02/28/2013 | WO2012123495A3 Functionalized biomaterials for tissue regeneration |
| 02/28/2013 | WO2012119113A3 Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures |
| 02/28/2013 | WO2012112589A9 Methods and compositions for detecting urinary cholesterol as a biomarker for acute kidney injury |
| 02/28/2013 | WO2012082912A9 Markers related to age-related macular degeneration and uses therefor |
| 02/28/2013 | WO2012075082A3 Method of evaluating performance characteristics |
| 02/28/2013 | WO2012074683A3 Detection of adenylate cyclase |
| 02/28/2013 | WO2010055529A3 Nontoxic, water-soluble and functionalized transition metal ion doped semiconductor nanocrystals and a process for the preparation thereof |
| 02/28/2013 | US20130055417 Hormone responsive tissue culture system and uses thereof |
| 02/28/2013 | US20130054150 System for tracking female fertility |
| 02/28/2013 | US20130054149 System and method for absolute quantification of proteins using lc/ms |
| 02/28/2013 | US20130054148 Interpretation |
| 02/28/2013 | US20130053432 In vivo gene sensors |
| 02/28/2013 | US20130053431 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 02/28/2013 | US20130053384 Certain Chemical Entities, Compositions, and Methods |
| 02/28/2013 | US20130053347 Pro-drugs of amaryllidaceae isocarbostyril products and their use against brain tumors |
| 02/28/2013 | US20130053338 Use of P2X Purinergic Receptor Agonists to Enhance Insulin Secretion in Pancreatic Beta Cells |
| 02/28/2013 | US20130053314 Mutant Epidermal Growth Factor Polypeptides with Improved Biological Activity and Methods of Their Making and Use |
| 02/28/2013 | US20130053284 Modular Roller Oven and Associated Methods |
| 02/28/2013 | US20130053277 Methods of identifying inhibitors of polypeptides-of-interest |
| 02/28/2013 | US20130053271 Self-Assembled Bead-Based Multiplexed Assay For Antigen-Specific Antibodies |
| 02/28/2013 | US20130053266 Ilcs based pattern recognition of sepsis |
| 02/28/2013 | US20130053265 Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia |
| 02/28/2013 | US20130053262 Mpl mutations in jak2 v617f negative patients with myeloproliferative disease |
| 02/28/2013 | US20130052751 Bio-threat microparticle simulants |
| 02/28/2013 | US20130052750 Diagnostic system |
| 02/28/2013 | US20130052747 Quantitative Analysis of a Function Group on the Surface of a Solid Material |